Medibio submits FDA 510K Application to FDA
Filed with ASX · · 2 pages · English
Story so far
Earlier from TrivarX
- Final Compass Pilot Completed Successfully
- Strategic Plan for FDA and CE Mark Approval
- Company Update
- Results of Annual General Meeting
- Pause in Trading
Later from TrivarX
- Placement and Fully Underwritten Entitlement Offer
- Entitlement Offer Booklet
- Entitlement Issue Results
- Patent Granted to Monitor Stress Conditions Using Heartrate
- Request For FDA Breakthrough Device Designation Submitted
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX